Om StandardX
StandardX udvikler en kompakt platform med en partikelaccelerator med høj effekt, der skal kunne producere flere isotoper fra en standardiseret installation. Virksomheden blev grundlagt i 2025 og fokuserer i første omgang på forsyning af isotoper til kræftdiagnostik og -behandling, forskning og fremtidige fusionssystemer.
What StandardX offers
StandardX is developing a scalable production platform for rare isotopes used in medicine, industry and energy. Its compact particle-accelerator architecture is intended to produce a versatile portfolio including diagnostic and therapeutic medical isotopes, industrial isotopes and tritium for fusion energy.
What sets StandardX apart
StandardX is building a repeatable isotope-production platform rather than a facility dedicated to a single isotope. The compact accelerator architecture is designed to translate specialised nuclear physics into distributed, scalable production for materials that are currently scarce or constrained by centralised supply.